Dipyrone is one of 136 small molecule programs targeting Delirium. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
230 competitors in Cesarean Section
Dipyrone
Marcaine
Pitocin
Naropin
Neo-Synephrine
Proamatine
Dynastat
Xylocaine
Ancef
Nubain
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources